FILING ANALYSIS · MONDAY, NOVEMBER 9
GeneDx Holdings Corp. WGS — 8-K: Results of Operations and Financial Condition
neutral
GeneDx reported third quarter 2026 revenue of $123.1 million, a 5% year-over-year increase, and expanded adjusted gross margin to 72%, but the results are largely in line with expectations, and the company is reiterating its full year 2026 revenue guidance of $475 to $490 million.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →